In T2DM with CKD, semaglutide reduced major kidney...

In T2DM with CKD, semaglutide reduced major kidney disease events at 3 y.

Abstract

SOURCE CITATION: Perkovic V, Tuttle KR, Rossing P, et al; FLOW Trial Committees and Investigators. Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. N Engl J Med. 2024;391:109-121. 38785209.

Authors

Collister D; Pannu N

Journal

Annals of Internal Medicine, Vol. 177, No. 9,

Publisher

American College of Physicians

Publication Date

September 1, 2024

DOI

10.7326/annals-24-01579-jc

ISSN

1056-8751

Associated Experts

David Collister

Assistant Clinical Professor (Adjunct), Faculty of Health Sciences

Visit profile

Labels